中华骨科杂志
中華骨科雜誌
중화골과잡지
CHINESE JOURNAL OF ORTHOPAEDICS
2011年
6期
692-698
,共7页
蔡郑东%胡硕%龚海洋%孙梦熊%李国东%李健
蔡鄭東%鬍碩%龔海洋%孫夢熊%李國東%李健
채정동%호석%공해양%손몽웅%리국동%리건
光化学疗法%激光%骨肉瘤%小鼠
光化學療法%激光%骨肉瘤%小鼠
광화학요법%격광%골육류%소서
Photochemotherapy%Lasers%Osteosarcoma%Mice
目的 观察光敏剂PSD-007对小鼠骨肉瘤细胞LM-8的体外及体内光动力效应.方法 PSD-007与LM-8细胞共同孵育后以激光照射,应用MTT法测定光密度(OD540)值,计算抑制率.40只C3H小鼠接种LM-8细胞,皮下瘤块直径7~8 mm时随机分为:(1)对照组,空白对照、生理盐水加光照、注射PSD-007不光照;(2)光动力治疗组,分别注射5mg/kg、10mg/kg PSD-007,6 h后以激光照射.1周后测量瘤体大小、重量,计算抑瘤率并行病理学检查.C3H小鼠30只建立肿瘤模型,肿瘤直径达10~12mm时,分别行肿瘤边缘切除无光动力治疗(对照组)、边缘切除后240 J/cm2光动力治疗及边缘切除后360 J/cm2光动力治疗.4周后比较肿瘤复发率.结果 体外只光照或只注射PSD-007对LM-8细胞均无杀伤作应.PSD-007浓度越高、激光照射强度越大,LM-8细胞OD540值越小.PSD-007浓度>4μg/ml,光照强度>6 J/cm2时,抑制率>50%.光镜下细胞形态呈坏死或凋亡样改变.体内实验显示光动力治疗组的肿瘤体积及瘤重均减小,肿瘤边缘切除高强度激光照射组的复发率较对照组低.结论 PSD-007对LM-8细胞有明确的光动力抑制效应,其作用大小取决于其浓度和激光照射强度.光动力疗法可以降低肿瘤边缘切除后的复发率.
目的 觀察光敏劑PSD-007對小鼠骨肉瘤細胞LM-8的體外及體內光動力效應.方法 PSD-007與LM-8細胞共同孵育後以激光照射,應用MTT法測定光密度(OD540)值,計算抑製率.40隻C3H小鼠接種LM-8細胞,皮下瘤塊直徑7~8 mm時隨機分為:(1)對照組,空白對照、生理鹽水加光照、註射PSD-007不光照;(2)光動力治療組,分彆註射5mg/kg、10mg/kg PSD-007,6 h後以激光照射.1週後測量瘤體大小、重量,計算抑瘤率併行病理學檢查.C3H小鼠30隻建立腫瘤模型,腫瘤直徑達10~12mm時,分彆行腫瘤邊緣切除無光動力治療(對照組)、邊緣切除後240 J/cm2光動力治療及邊緣切除後360 J/cm2光動力治療.4週後比較腫瘤複髮率.結果 體外隻光照或隻註射PSD-007對LM-8細胞均無殺傷作應.PSD-007濃度越高、激光照射彊度越大,LM-8細胞OD540值越小.PSD-007濃度>4μg/ml,光照彊度>6 J/cm2時,抑製率>50%.光鏡下細胞形態呈壞死或凋亡樣改變.體內實驗顯示光動力治療組的腫瘤體積及瘤重均減小,腫瘤邊緣切除高彊度激光照射組的複髮率較對照組低.結論 PSD-007對LM-8細胞有明確的光動力抑製效應,其作用大小取決于其濃度和激光照射彊度.光動力療法可以降低腫瘤邊緣切除後的複髮率.
목적 관찰광민제PSD-007대소서골육류세포LM-8적체외급체내광동력효응.방법 PSD-007여LM-8세포공동부육후이격광조사,응용MTT법측정광밀도(OD540)치,계산억제솔.40지C3H소서접충LM-8세포,피하류괴직경7~8 mm시수궤분위:(1)대조조,공백대조、생리염수가광조、주사PSD-007불광조;(2)광동력치료조,분별주사5mg/kg、10mg/kg PSD-007,6 h후이격광조사.1주후측량류체대소、중량,계산억류솔병행병이학검사.C3H소서30지건립종류모형,종류직경체10~12mm시,분별행종류변연절제무광동력치료(대조조)、변연절제후240 J/cm2광동력치료급변연절제후360 J/cm2광동력치료.4주후비교종류복발솔.결과 체외지광조혹지주사PSD-007대LM-8세포균무살상작응.PSD-007농도월고、격광조사강도월대,LM-8세포OD540치월소.PSD-007농도>4μg/ml,광조강도>6 J/cm2시,억제솔>50%.광경하세포형태정배사혹조망양개변.체내실험현시광동력치료조적종류체적급류중균감소,종류변연절제고강도격광조사조적복발솔교대조조저.결론 PSD-007대LM-8세포유명학적광동력억제효응,기작용대소취결우기농도화격광조사강도.광동력요법가이강저종류변연절제후적복발솔.
Objective To evaluate the PSD-007-mediated photodynamic effect on mouse osteosarcoma cell line LM-8, both in vitro and in vivo. Methods LM-8 cells were incubated with different concentrations of PSD-007 for 4 hours and then followed different laser irradiations. After photodynamic therapy (PDT), cell viability was measured using MTT assay and the optical density in each experiment was measured at 450 nm with a micro plate reader. The inhibition rate of cell growth was calculated. Four-week-old female C3H mice were used for implantation of LM-8 cells. When the diameter of tumor reached up to 7-8 mm, the mice were randomly divided into following groups: 1) control group, including untreated control, saline with laser irradiation, PSD-007 without laser irradiation; 2) PDT group, PSD-007 (5 and 10 mg/kg) was injected intravenously into the mice, and the tumor site was irradiated with laser light 6 hours after injection. Seven days after PDT, the size and weight of the tumors were measured. The inhibition rate of tumor was calculated, and all tumor specimens were taken for pathologic examination. After the diameter of tumor was 10-12 mm, the tumors were performed a marginal resection and subsequently followed 3 different treatments: without PDT (control), PDT with 240 J/cm2 or 360 J/cm2 laser irradiation. After 4 weeks treatment, the tumor recurrence rates were analyzed. Results MTT assay revealed that the cytotoxic effect of PDT on the LM-8 cells was positively correlated with the concentration of PSD-007 and the level of laser irradiation. When the concentration exceeded 4μg/ml, and the energy exceeded 6 J/cm2, the inhibition ratio was over 50%. No anti-tumor effect was observed in the cells treated with only laser irradiation or PSD-007 injection. Compared with the control group, the size and weight of the tumors were obviously decreased after PDT. PDT performed after marginal resection of the tumor reduced the rate of local recurrence. Conclusion PDT with PSD-007 showed cytotoxic effect on the LM-8 cells, and which performed after marginal resection of the tumor reduced the rate of local recurrence.